MedTrace Logo

Amino Acid-based Oral Rehydration Solution in Children With Short Bowel Syndrome

NCT03105362 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2020-02-24

Study results available
· View outcomes & findings →

Summary

This study will assess the tolerability and palatability of an amino acid based oral rehydration solution (enterade®) compared to current oral rehydration solution among children with short bowel syndrome .

Conditions

  • Short Bowel Syndrome

Interventions

DIETARY_SUPPLEMENT

Enterade® oral rehydration solution

Commercially available amino acid based oral rehydration solution

Sponsors & Collaborators

Principal Investigators

  • Christopher P Duggan, MD · Boston Children's Hospital

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Year
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-16
Primary Completion
2018-01-20
Completion
2018-04-03

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03105362 on ClinicalTrials.gov